NO873593L - Vaksine. - Google Patents

Vaksine.

Info

Publication number
NO873593L
NO873593L NO873593A NO873593A NO873593L NO 873593 L NO873593 L NO 873593L NO 873593 A NO873593 A NO 873593A NO 873593 A NO873593 A NO 873593A NO 873593 L NO873593 L NO 873593L
Authority
NO
Norway
Prior art keywords
proteins
adjuvant
vaccine
picornavirus
poliovirus
Prior art date
Application number
NO873593A
Other languages
English (en)
Norwegian (no)
Other versions
NO873593D0 (no
Inventor
Antonius Ludovicus Van Vezel
Antonius Gerardus Hazendonk
Eduard Coen Beuvery
Original Assignee
Nl Mini Welzijn Gesund Cultur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nl Mini Welzijn Gesund Cultur filed Critical Nl Mini Welzijn Gesund Cultur
Publication of NO873593D0 publication Critical patent/NO873593D0/no
Publication of NO873593L publication Critical patent/NO873593L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32622New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO873593A 1986-08-27 1987-08-26 Vaksine. NO873593L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/900,739 US4946676A (en) 1986-08-27 1986-08-27 Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide

Publications (2)

Publication Number Publication Date
NO873593D0 NO873593D0 (no) 1987-08-26
NO873593L true NO873593L (no) 1988-02-29

Family

ID=25413018

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873593A NO873593L (no) 1986-08-27 1987-08-26 Vaksine.

Country Status (10)

Country Link
US (1) US4946676A (da)
EP (1) EP0257721B1 (da)
JP (1) JPS63132844A (da)
AT (1) ATE71534T1 (da)
CA (1) CA1292690C (da)
DE (1) DE3776034D1 (da)
DK (1) DK169276B1 (da)
ES (1) ES2032812T3 (da)
GR (1) GR3003754T3 (da)
NO (1) NO873593L (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797270B1 (en) * 1989-03-16 2004-09-28 Center For Blood Research, Inc. Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy
CA2105629A1 (en) * 1992-09-14 1994-03-15 Robert S. Becker Potentiation of immunogenic response
EP1409551A4 (en) * 2001-06-21 2004-10-13 Uab Research Foundation CHEMICAL CAPSIDE PROTEINS AND USES THEREOF
US20040002058A1 (en) * 2001-06-21 2004-01-01 Uab Research Foundation Chimeric capsid proteins and uses thereof
US20090142364A1 (en) * 2007-08-30 2009-06-04 Fedor Alexandrovich Brovko Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use
WO2016205389A1 (en) 2015-06-15 2016-12-22 Emory University Multivalent enterovirus vaccine compositions and uses related thereto
CN110603046B (zh) * 2016-03-20 2022-10-18 宾夕法尼亚州立大学托管会 用于提高高等植物叶绿体中转基因表达的密码子优化和核糖体图谱分析

Also Published As

Publication number Publication date
JPS63132844A (ja) 1988-06-04
US4946676A (en) 1990-08-07
EP0257721A3 (en) 1988-06-08
DK446287A (da) 1988-02-28
EP0257721B1 (en) 1992-01-15
DK169276B1 (da) 1994-10-03
DE3776034D1 (de) 1992-02-27
DK446287D0 (da) 1987-08-26
GR3003754T3 (da) 1993-03-16
EP0257721A2 (en) 1988-03-02
CA1292690C (en) 1991-12-03
NO873593D0 (no) 1987-08-26
ES2032812T3 (es) 1993-03-01
ATE71534T1 (de) 1992-02-15

Similar Documents

Publication Publication Date Title
DE69333397D1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
ATE115187T1 (de) Poxvirus-vektoren.
DE68924162T2 (de) Stressproteine und verwendungen dafür.
ES2002490A6 (es) Un metodo de preparar un virus recombinante
NO932423D0 (no) Ekspresjon av rekombinante proteiner i attenuerte bakterier
ATE364083T1 (de) Immunogene zusammensetzungen gegen eine helicobacterinfektion, verwendung von polypeptiden in diesen zusammensetzungen und nukleinsäurendie besagte polypeptide kodieren
ATE109830T1 (de) Expression von virusproteinen mit immunologischer aktivität.
ATE71534T1 (de) Vakzine.
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
KR980000469A (ko) Hbv 항원단백질을 발현하는 키메라 폴리오바이러스 백신벡터를 이용한 면역화 방법